Company · CIK 0000720154 · SIC 8731 — Services-Commercial Physical & Biological Research
Inotiv, Inc. · NOTVQ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2026 JForm 4 → | Jul 20, 4:39 pm EDT | Nigel BrownDirector | 104,929 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:38 pm EDT | Beth A. TaylorChief Financial Officer | 139,616 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:36 pm EDT | John E SagartzChief Strategy Officer, Director | 729,626 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:35 pm EDT | R Matthew NeffDirector | 151,102 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:34 pm EDT | David LandmanDirector | 216,243 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:32 pm EDT | Adrian HardyChief Commercial Officer | 53,049 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:31 pm EDT | Michael J HarringtonDirector | 76,892 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:29 pm EDT | Jeffrey Brennan FreemanVP-Finance & Corp. Controller | 36,623 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:27 pm EDT | Mary Theresa CoelhoDirector | 74,303 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:26 pm EDT | Andrea CastetterEVP, GC, Sec'y & CCO | 49,200 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:25 pm EDT | John Gregory BeattieChief Operating Officer | 180,992 | — | — | 0 | — | |
| Jul 19, 2026 JForm 4 → | Jul 20, 4:22 pm EDT | Robert Leasure Jr.President and CEO, Director | 1,361,215 | — | — | 0 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:08 pm EDT | Beth A. TaylorChief Financial Officer | 5,864 | $0.0185 | $108 | 139,616 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:07 pm EDT | John E SagartzChief Strategy Officer, Director | 6,071 | $0.0185 | $112 | 729,626 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:06 pm EDT | Adrian HardyChief Commercial Officer | 5,371 | $0.0185 | $99 | 53,049 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:06 pm EDT | Jeffrey Brennan FreemanVP-Finance & Corp. Controller | 5,855 | $0.0185 | $108 | 36,623 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:05 pm EDT | Andrea CastetterEVP, GC, Sec'y & CCO | 5,800 | $0.0185 | $107 | 49,200 | — | |
| Jun 18, 2026 FForm 4 → | Jun 23, 4:05 pm EDT | John Gregory BeattieChief Operating Officer | 5,769 | $0.0185 | $107 | 180,992 | — | |
| Mar 8, 2019 PForm 4 → | Mar 11, 4:10 pm EDT | Robert Leasure Jr.President and CEO, Director | 4,000 | $1.77 | $7,080 | 93,615 | +4.46% | plan? |
| Mar 8, 2019 PForm 4 → | Mar 11, 4:09 pm EDT | R Matthew NeffDirector | 5,715 | $1.75 | $10,001 | 20,715 | +38.1% | plan? |
| Mar 6, 2019 PForm 4 → | Mar 7, 4:17 pm EST | Daniel Thomas OakleyChief Operating Officer | 10,000 | $1.75 | $17,500 | 20,951 | +91.3% | plan? |
| Mar 1, 2019 PForm 4 → | Mar 5, 4:34 pm EST | Daniel Thomas OakleyChief Operating Officer | 125 | $1.54 | $193 | 10,951 | +1.15% | plan? |
| Feb 28, 2019 PForm 4 → | Mar 1, 5:12 pm EST | Robert Leasure Jr.President and CEO, Director | 18,900 | $1.57 | $29,639 | 89,615 | +26.7% | plan? |
| Feb 27, 2019 PForm 4 → | Feb 28, 5:15 pm EST | Daniel Thomas OakleyChief Operating Officer | 10,826 | $1.53 | $16,564 | 10,826 | — | plan? |
| Feb 19, 2019 LForm 4 → | Mar 1, 5:16 pm EST | John E SagartzDirector, 10% Owner | 2,500 | $1.43 | $3,575 | 2,500 | — | plan? late |
| Jan 14, 2019 AForm 4 → | Jan 16, 4:05 pm EST | Robert Leasure Jr.President and CEO, Director | 44,615 | — | — | 70,715 | — | plan? |
| Sep 14, 2018 PForm 4 → | Sep 18, 9:50 pm EDT | Peter Kissinger +110% Owner | 10,000 | $1.74 | $17,382 | 1,033,457 | +0.98% | plan? |
| Sep 14, 2018 PForm 4 → | Sep 18, 4:09 pm EDT | R Matthew NeffDirector | 2,500 | $1.66 | $4,150 | 15,000 | +20.0% | plan? |
| Sep 13, 2018 LForm 4 → | Sep 18, 4:09 pm EDT | Jill BlumhoffVP, Finance & CFO | 450 | $1.62 | $729 | 1,311 | — | plan? late |
| Sep 12, 2018 LForm 4 → | Sep 18, 4:09 pm EDT | R Matthew NeffDirector | 2,500 | $1.65 | $4,125 | 12,500 | — | plan? late |
| Sep 11, 2018 PForm 4 → | Sep 12, 4:19 pm EDT | Philip A DowningSr. VP, Preclinical Srvcs. | 5,000 | $1.67 | $8,350 | 20,765 | +31.7% | plan? |
| Feb 16, 2018 PForm 4 → | Feb 20, 4:17 pm EST | Philip A DowningSr. VP, Preclinical Srvcs. | 5,000 | $1.46 | $7,300 | 15,765 | +46.4% | plan? |
| Sep 8, 2017 PForm 4 → | Sep 8, 4:16 pm EDT | R Matthew NeffDirector | 5,000 | $1.50 | $7,500 | 10,000 | +100% | plan? |
| Aug 18, 2017 PForm 4 → | Aug 23, 10:23 am EDT | Gregory Cole DavisDirector | 5,000 | $1.70 | $8,500 | 5,000 | — | plan? late |
| Aug 18, 2017 PForm 4 → | Aug 23, 10:23 am EDT | R Matthew NeffDirector | 5,000 | $1.70 | $8,500 | 5,000 | — | plan? late |
| Mar 15, 2017 FMForm 4 → | Mar 17, 4:36 pm EDT | Jill BlumhoffVP, Finance & CFO | 4,139 | $1.31 | $5,441 | 861 | — | plan? |
| Mar 1, 2017 FMForm 4 → | Mar 15, 5:39 pm EDT | Philip A DowningVP, Preclinical Srvcs. | 16,235 | $1.24 | $20,201 | 10,765 | — | plan? late |
| May 27, 2016 PForm 4 → | May 27, 4:05 pm EDT | Connie Leigh DoughertyVP, Business Development | 423 | $0.92 | $389 | 9,074 | +4.89% | plan? |
| May 23, 2016 PForm 4 → | May 25, 4:51 pm EDT | Connie Leigh DoughertyVP, Business Development | 96 | $0.92 | $88 | 8,651 | +1.12% | plan? |
| May 19, 2016 PForm 4 → | May 23, 4:29 pm EDT | Connie Leigh DoughertyVP, Business Development | 1,655 | $0.92 | $1,523 | 8,555 | +24.0% | plan? |
| Feb 29, 2016 PForm 4 → | Mar 2, 5:04 pm EST | Jacqueline M LemkePresident and CEO, Director | 10,000 | $1.18 | $11,762 | 9,000 | — | plan? |
| Sep 14, 2015 PForm 4 → | Sep 16, 11:52 am EDT | Philip A DowningVP, Preclinical Srvcs. | 3,000 | $1.73 | $5,190 | 7,000 | +75.0% | plan? |
| Aug 21, 2015 PForm 4 → | Aug 25, 5:20 pm EDT | Connie Leigh DoughertyVP, Business Development | 6,900 | $1.42 | $9,798 | 6,900 | — | plan? |
| Jun 18, 2015 FMForm 4 → | Jun 22, 4:28 pm EDT | Jacqueline M LemkePresident and CEO, Director | 222,315 | $1.70 | $378,448 | 56,685 | — | plan? |
| Feb 27, 2015 PForm 4 → | Mar 3, 6:30 pm EST | Jacqueline M LemkePresident and CEO, Director | 10,000 | $2.04 | $20,400 | 3,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2019 AForm 4 → | Feb 12, 4:47 pm EST | R Matthew NeffDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:47 pm EST | Gregory Cole DavisDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:47 pm EST | Richard Allen JohnsonDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:46 pm EST | Wendy PerrowDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:46 pm EST | Philip A DowningSr. VP, Preclinical Srvcs. | 25,000 | — | — | 25,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:46 pm EST | Jill BlumhoffVP, Finance & CFO | 25,000 | — | — | 25,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:45 pm EST | Michael BaimVP Bioanalytical Services | 15,000 | — | — | 15,000 | — | |
| Feb 8, 2019 AForm 4 → | Feb 12, 4:45 pm EST | Daniel Thomas OakleyChief Operating Officer | 35,000 | — | — | 35,000 | — | |
| Jan 14, 2019 AForm 4 → | Jan 16, 4:05 pm EST | Robert Leasure Jr.President and CEO, Director | 55,000 | — | — | 55,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:04 pm EDT | R Matthew NeffDirector | 10,000 | — | — | 10,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:04 pm EDT | Wendy PerrowDirector | 10,000 | — | — | 10,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:03 pm EDT | Gregory Cole DavisDirector | 10,000 | — | — | 10,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:03 pm EDT | Richard Allen JohnsonDirector | 10,000 | — | — | 10,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:02 pm EDT | Philip A DowningVP, Preclinical Srvcs. | 20,000 | — | — | 20,000 | — | |
| Oct 27, 2017 AForm 4 → | Oct 31, 5:02 pm EDT | Jill BlumhoffVP, Finance & CFO | 20,000 | — | — | 20,000 | — | |
| Mar 15, 2017 MForm 4 → | Mar 17, 4:36 pm EDT | Jill BlumhoffVP, Finance & CFO | 700 | — | — | 0 | — | |
| Mar 1, 2017 MForm 4 → | Mar 15, 5:39 pm EDT | Philip A DowningVP, Preclinical Srvcs. | 10,000 | — | — | 0 | — | late |
| May 13, 2016 AForm 4 → | May 16, 4:11 pm EDT | Jill BlumhoffVP, Finance & CFO | 10,000 | — | — | 10,000 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:28 pm EDT | Jacqueline M LemkePresident and CEO, Director | 125,500 | — | — | 0 | — | |
| Mar 13, 2015 AForm 4 → | Mar 17, 4:29 pm EDT | Philip A DowningVP, Preclinical Srvcs. | 10,000 | — | — | 10,000 | — |